In addition to treating diseases by modulating palmitoylation-related enzymes, therapeutic agents can target specific palmitoylated cysteine residues, such as C176/178, H-151, NO2-FAs or nitrofuran molecules, which can block STING palmitoylation modification by covalently modifying the Cys91 residue of STING, inhibiting type I interferon signaling, and providing a new therapeutic target for STING-associated diseases by blocking STING palmitoylation and inhibiting type I interferon signaling (103, 251)
Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat Parkinsons disease
A strategic leader with demonstrated success in recognizing and maximizing individual, agency, and cross-functional team strengths, Paige is part cheerleader and change agent, bringing innovative and customer-focused approaches through disrupting the status quo
Published 2018 Aug 26
Whats more, its sweet, delicious, and packed with water, making it excellent for maintaining good hydration